.dropcap {float:left; color:#4791d2; font-size:75px; line-height:60px; padding-top:4px; padding-right:8px; padding-left:3px; font-family:Georgia}

Google+ Followers


Friday, May 22, 2015

Two Warnings About Blood-Thinners

Gosh, it may have been 12:25 a.m. or more before I got to bed last night ─ it is crippling having to finish up a post here late in the evening because I run out of time in the late afternoon.

I think it was around 8:15 a.m. this morning when I decided to rise for the day, but it took a few minutes to actually tear myself away from lying in bed.  

And even then, I felt unwell.  I felt ill-rested; and my body ached nearly as if I had spent the previous day doing manual labour.

At times like that, I find myself wondering how it's possible that I will eventually normalize over the course of the morning and actually engage in some exercising ─ it would certainly be an impossibility if I remained feeling as I was then.

As far as I am concerned, it is a fiction that anyone can wake up feeling so damned good that they leap from bed, and can do push-ups or knee-bends, all while wearing a smile of radiance.

I almost have to hold the railing as I stiffly and with some pain hobble down the stairs for that first mug of blended instant coffee/cocoa powder.

I don't believe that I said aught thus far this week, but my youngest step-son Pote has worked ─ as part of his Grade XII job-experience programme ─ every day this work week from 1:00 p.m. to 6:00 p.m. at the Starbucks over near the King George Skytrain Station.

This is his first week at it, although he did also put in some time last Saturday.

I think he is expected to either put in 100 hours, or else do it for three weeks.

His older working brother Tho was home during the noon-hour today to stay ─ apparently it was a short day for him where he works.  That happens for him sometimes on Fridays.  Tho also got paid today; and his shirking of attendance is showing ─ his direct deposit wasn't quite $640.

That averages out to about a daily working-day income of a mere $64 for the past two weeks ─ he's got to smarten up.

We haven't enjoyed today the amount of sunshine that had prevailed for a fair stretch of previous days, but nonetheless I ventured out into the backyard this afternoon and sat in a chair on the lawn facing toward the Sun.  

Sometimes it shone directly and fiercely upon me; but I think that the majority of the time, I experienced the clouding.

I suppose I benefited from at least 25 minutes out there, but it was generally too cool to have on just a pair of shorts (which I did not ─ I wore jeans).  I never even removed my sleeveless top ─ that was as daring as I felt myself comfortable with.


I do not recall ever hearing of a blood-thinner called Effient, but the following report published about three days ago by the Health Sciences Institute (HSI) should be sufficient to steer away anyone from it who can still think for themselves:

Blood money
Six years ago the FDA received an alarming... even chilling... letter about Effient, a new blood thinner the agency was set to approve.

The letter warned of uncontrollable bleeding, trial data that may have been rigged, and that Effient may unleash a tidal wave of cancer.

The letter came from Dr. Victor Serebruany. He's one of the world's leading experts on blood thinners -- and he's also Effient's inventor.

It's been six years since Dr. Serebruany was unable to protect us villagers from the monster he created. Six years since the FDA bowed to pressure from a $23 billion drug giant and put the drug on the market.

Now the numbers are coming in. They're proving that Dr. Serebruany's nightmare scenario is coming true -- and that you shouldn't allow Effient within 10 feet of your medicine cabinet.

It's pretty unusual for Congress to launch an inquiry into a drug that hasn't had its first paying customer yet.

But if there was any drug that deserved the full Watergate treatment, it was Effient, a prescription blood thinner that's often given after you've had an angioplasty.

In 2009, just two days before a key FDA advisory panel was set to meet on Effient, drugmaker Eli Lilly made a disturbing call to the FDA.

They demanded that Dr. Sanjay Kaul from Cedars-Sinai Medical Center in Los Angeles be kicked out of the meeting. Dr. Kaul, a world-famous cardiologist, had apparently been doing his job and raising concerns about Effient's safety.

But Eli Lilly wasn't just settling a score with Dr. Kaul -- it was trying to keep a growing mutiny from spinning out of control.

Dr. Serebruany, a Johns Hopkins researcher who helped develop Effient for Eli Lilly, had broken ranks and was warning cardiologists and regulators everywhere that Effient was too dangerous to be approved. And his message was starting to resonate.

The problems started with the disastrous TRITON-TMI 38 study that was supposed to show that Effient worked at least as well as other blood thinners on the market -- and that it was safe.

Instead, when Dr. Serebruany and other researchers crunched the numbers, they found that Effient increased the "risk of fatal hemorrhage fourfold" -- and that was after Eli Lilly allegedly stacked the deck to give Effient an advantage over other drugs.

Even more disturbing, Dr. Serebruany and his colleagues noticed a disturbing rash of aggressive cancers among patients on Effient. Your body's platelets work to naturally stop the spread of slower growing, less threatening tumors -- and it seemed Effient was keeping those platelets from doing their job.

Dr. Serebruany wasn't ready to call Effient a carcinogen -- but he was certain it was a "cancer promoter."

Neither the FDA nor Congress had the backbone to keep Effient off the market -- and none of the warnings nor concerns could stop the Eli Lilly marketing machine from turning it into a half-a-billion-dollar-a-year drug.

But now a second mutiny is forming against the drug -- and this time it's being led by cardiologists who are learning firsthand that the benefits of Effient don't outweigh the risks.

At a recent major cardiology conference in San Diego, researchers said they couldn't produce any evidence that Effient works any better than a slew of other blood thinners now being used.

There's no "statistically significant" evidence that it's saving lives -- but it may be ending plenty.

A second look from the original Effient trials found that people taking the drug had a 60 percent higher rate of either new or worsened solid tumors -- especially the kind that can spread quickly. And the longer you stay on the drug, the greater your chances of a life-threatening cancer.

That's especially dangerous because, as Dr. Serebruany points out, many patients who have had an angioplasty stay on blood thinners like Effient forever.

If you've been prescribed Effient, talk to your doctor about suitable replacements.

And if you haven't been prescribed the drug, there may be good news ahead. Cardiologists are learning more about the dangers of Effient, and it's coming off patent in just a few years.

That means both doctors and Eli Lilly may soon be losing interest in forcing this drug down our throats.

Unfortunately, it's six years too late.
It truly goes to show that ─ especially in the U.S. ─ governments cannot be relied upon to protect the public when it comes to major pharmaceutical organizations.  There's just too much money to be made ─ and I don't strictly mean earnings generated by the drugs for the companies.  I am also referring to the huge sums of money politicians and government regulators are rewarded with by those drug corporations.

I could not say that I had ever heard of Effient, but I most definitely know of Warfarin ─ this report was published a couple of days ago by Dr. William Campbell Douglass II:

Overweight? This common heart drug could be KILLING you
If you've ever had a battle with rats, you know how tough those little buggers are. Some of them just don't know how to die!

Years ago, one of the most effective ways to kill a rat was to leave out a poison containing the very same warfarin that's used as a blood thinner by millions of Americans today.

It worked... for a little while. But it's less effective these days as the rats become resistant to it.

But for us humans, the exact OPPOSITE is happening.

As time goes on, we're not getting more resistant to it. We're getting more HURT by it -- and new research spots the surprising reason: The fatter we get, the more likely we are to suffer the drug's infamous risk of internal bleeding.

If your warfarin levels inch a little over the line, you could suddenly start bleeding like a stuck pig.

Any higher, and you face the risk of more serious and even potentially deadly internal bleeding.

Those are risks that could strike ANYONE on this bad-news med, but new research finds that the beefier you are, the bigger your risk. And if you're obese, your risk of serious internal bleeding due to warfarin jumps by a staggering 84 percent.

Naturally, all the blah-blah-blah from the mainstream is about how this study means the drug should be used "with caution," especially among the obese.

PUH-leaze!!! Talk about preaching to the deaf. These people are giving RAT POISON to PEOPLE for crying out loud -- so they clearly tossed caution out the window years ago.

Poison is poison, and even in the best of circumstances -- even if you're not obese -- this drug could do you in. And in the worst of circumstances? Well, I suggest you never find out.

The best natural way to thin the blood is with old-fashioned cod liver oil. Two to three tablespoons per day should do the trick for most people, but if you're on rat poison don't suddenly stop taking it on your own as that can come with its own risks.

Work closely with a naturopathic medical doctor who can get you safely off the poison and onto cod liver oil and other safe alternatives.

Stopping the flow,

William Campbell Douglass II, M.D.
I sought the study he referred to, but evidently only an abstract was presented to a body of medical specialists who had gathered recently.

That document came from the American Heart Association website ─ as does this brief report on the abstract presentation:  Obese patients may be at higher risk of bleeding when taking warfarin.

Here are three other reports on it, if anyone is interested:
Do whatever you have to in order to be free of these infernal blood-thinners.


Here now to close today's post is an entry from my journal of 41 years ago when I was 24 years old, and living for the month of May in a cheap housekeeping room in New Westminster I was forced to rent.
WEDNESDAY, May 22, 1974

I had a NE about 6:00 a.m.

Today apparently was Mayday, for after walking through the misty beginnings of an extended downpour to Safeway for 3 heads of lettuce, I returned through Queen's Park on my way to Mark's; the carnival was set up, but still.

My workout today was quite good; and 'cause Cathy is now on night shift, she drove me home where I finished my free-style routine.

Still it pours.
You may not, but I rather get a kick out of the mentions I made of personal details like that of having an "NE" (nocturnal emission).

Those are history for me now, though ─ I haven't had one in a few decades.

My younger brother Mark was then living in a rented home he shared with his wonderful girlfriend ─ Catherine Jeanette Gunther ─ out in Whalley.

I had just recently bought a set of weights, and was keeping them at their home because my housekeeping room was too cramped...and a temporary abode.
Did I really buy the lettuce to take with me out to their home?  Or did I mean that after taking the lettuce to my room (at 333 Pine Street, I think), I said that I was returning to their home because I had just been there the previous evening?

Regardless, May Day was always quite a celebration in New Westminster, and Queen's Park figured rather largely in that.

"Cathy" ─ or Jeanette, as he preferred to be called ─ worked in New Westminster at Scott Paper.  It would have been just about nothing for the dear creature to have given me a ride home when she headed into town for her 11:00 p.m. shift start.

Once home, I evidently did some further body-weight exercising ─ whatever it might have involved.
Post a Comment